180 related articles for article (PubMed ID: 36837487)
1. Evaluating the Magnolol Anticancer Potential in MKN-45 Gastric Cancer Cells.
Naghashpour M; Dayer D; Karami H; Naghashpour M; Moghadam MT; Haeri SMJ; Suzuki K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837487
[No Abstract] [Full Text] [Related]
2. Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/Akt signaling pathways.
Rasul A; Yu B; Khan M; Zhang K; Iqbal F; Ma T; Yang H
Int J Oncol; 2012 Apr; 40(4):1153-61. PubMed ID: 22139054
[TBL] [Abstract][Full Text] [Related]
3. Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
Zhang FH; Ren HY; Shen JX; Zhang XY; Ye HM; Shen DY
Biomed Pharmacother; 2017 Oct; 94():474-480. PubMed ID: 28779709
[TBL] [Abstract][Full Text] [Related]
4. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
[TBL] [Abstract][Full Text] [Related]
5. Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway.
Park JB; Lee MS; Cha EY; Lee JS; Sul JY; Song IS; Kim JY
Biol Pharm Bull; 2012; 35(9):1614-20. PubMed ID: 22975518
[TBL] [Abstract][Full Text] [Related]
6. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
7. Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells.
Vasefifar P; Najafi S; Motafakkerazad R; Amini M; Safaei S; Najafzadeh B; Alemohammad H; Jafarlou M; Baradaran B
Exp Cell Res; 2023 Aug; 429(2):113681. PubMed ID: 37315760
[TBL] [Abstract][Full Text] [Related]
8. Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
Chilampalli C; Guillermo R; Zhang X; Kaushik RS; Young A; Zeman D; Hildreth MB; Fahmy H; Dwivedi C
BMC Cancer; 2011 Oct; 11():456. PubMed ID: 22014088
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Magnolol combined with Gefitinib on A549 non-small cell lung cancer cells].
Ren JL; Cui LZ; Hao XX; Li XY; Chang YX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Sep; 37(5):506-510. PubMed ID: 34816662
[No Abstract] [Full Text] [Related]
10. Anticancer potential of magnolol for lung cancer treatment.
Seo JU; Kim MH; Kim HM; Jeong HJ
Arch Pharm Res; 2011 Apr; 34(4):625-33. PubMed ID: 21544728
[TBL] [Abstract][Full Text] [Related]
11. 2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma.
Wang TH; Fang JY; Wu SJ; Liu YW; Chan CW; Chuang SY; Chen CY
Cell Physiol Biochem; 2018; 50(3):883-892. PubMed ID: 30355952
[TBL] [Abstract][Full Text] [Related]
12. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
13. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells.
Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS
In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689
[TBL] [Abstract][Full Text] [Related]
14. Magnolol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity through activation of mitochondrial function.
Choi EM
Inflammation; 2012 Jun; 35(3):1204-12. PubMed ID: 22281543
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Magnolol on Proliferation and Apoptosis of HL-60 Cells and Its Molecular Mechanism].
Fang K; Yuan XF; Liao Q; Zhang ZY; Song GH; Guo Q; Ren X; Jiang GS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):388-93. PubMed ID: 27150997
[TBL] [Abstract][Full Text] [Related]
16. Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1.
Chen LC; Liu YC; Liang YC; Ho YS; Lee WS
J Agric Food Chem; 2009 Aug; 57(16):7331-7. PubMed ID: 19645506
[TBL] [Abstract][Full Text] [Related]
17. Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway.
Zhou Y; Bi Y; Yang C; Yang J; Jiang Y; Meng F; Yu B; Khan M; Ma T; Yang H
Pharmazie; 2013 Sep; 68(9):755-62. PubMed ID: 24147344
[TBL] [Abstract][Full Text] [Related]
18. Compare the Effects of Magnolol on Gastric Cancer Cells Through c-Jun N-Terminal Kinase Signaling Pathway and Gold Magnetic.
Chen Y; He X; Feng D; Li S
J Nanosci Nanotechnol; 2021 Feb; 21(2):943-948. PubMed ID: 33183428
[TBL] [Abstract][Full Text] [Related]
19. Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight.
Wang X; Liu Q; Fu Y; Ding RB; Qi X; Zhou X; Sun Z; Bao J
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234977
[TBL] [Abstract][Full Text] [Related]
20. Suppression of PKCδ/NF-κB Signaling and Apoptosis Induction through Extrinsic/Intrinsic Pathways Are Associated Magnolol-Inhibited Tumor Progression in Colorectal Cancer In Vitro and In Vivo.
Su CM; Weng YS; Kuan LY; Chen JH; Hsu FT
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
